Engineering of an isolated p110 alpha subunit of PI3K alpha permits crystallization and provides a platform for structure-based drug design.
Chen, P., Deng, Y.L., Bergqvist, S., Falk, M.D., Liu, W., Timofeevski, S., Brooun, A.(2014) Protein Sci 23: 1332-1340
- PubMed: 25043846 
- DOI: 10.1002/pro.2517
- Primary Citation of Related Structures:  
4TV3, 4TUU - PubMed Abstract: 
PI3Kα remains an attractive target for the development of anticancer targeted therapy. A number of p110α crystal structures in complex with the nSH2-iSH2 fragment of p85 regulatory subunit have been reported, including a few small molecule co-crystal str ...